Bilaketaren emaitzak - Rotshteyn, Yakov

Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteers nork Gale, Donna Donigi, Landells, Linda J, Spina, Domenico, Miller, Alan J, Smith, Kate, Nichols, Terry, Rotshteyn, Yakov, Tonelli, Alfred, Lacouture, Peter, Burch, Ronald M, Page, Clive P, O'Connor, Brian J

Testu osoa Testu osoa Testu osoa

Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody nork Jacobson, Jeffrey M., Thompson, Melanie A., Lalezari, Jacob P., Saag, Michael S., Zingman, Barry S., D’Ambrosio, Paul, Stambler, Nancy, Rotshteyn, Yakov, Marozsan, Andre J., Maddon, Paul J., Morris, Stephen A., Olson, William C.

Testu osoa Testu osoa Testu osoa

Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture nork Coburn, Glen A., Fisch, Danielle N., Moorji, Sameer M., de Muys, Jean-Marc, Murga, Jose D., Paul, Dorothy, Provoncha, Kathleen P., Rotshteyn, Yakov, Han, Amy Q., Qian, Dapeng, Maddon, Paul J., Olson, William C.

Testu osoa Testu osoa Testu osoa

Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults nork Jacobson, Jeffrey M., Lalezari, Jacob P., Thompson, Melanie A., Fichtenbaum, Carl J., Saag, Michael S., Zingman, Barry S., D'Ambrosio, Paul, Stambler, Nancy, Rotshteyn, Yakov, Marozsan, Andre J., Maddon, Paul J., Morris, Stephen A., Olson, William C.

Testu osoa Testu osoa Testu osoa